After decades of investigating the molecular mysteries behind aging and disease, Monica Driscoll last spring faced a puzzling new problem. How would her team of nearly two dozen researchers – comprising one of Rutgers University’s largest and most prominent science labs – continue its work during Covid-19? Driscoll, a molecular neuro-geneticist in the School of Arts and Sciences at Rutgers-New Brunswick, seeks to discover the ways in which humans might extend healthy lifespan. Her research tackles illnesses like Alzheimer’s disease and ALS and draws extensive funding from the National Institutes of Health. It’s not a job that can be handled over Zoom. To read the full story.